PARP Inhibitor Combinations in Prostate Cancer: Expanding Treatment Options to Broader Patient Populations

Learn how experts incorporate the newest evidence from ASCO 2021 on PARP inhibitor&ndash based combinations into optimal management of prostate cancer with an on-demand webcast from a live webinar plus an expert commentary podcast and downloadable slidesets with ExpressPoints slides.

Share

Program Content

Activities

PARPi Combos in Prostate Cancer
PARP Inhibitor Combinations in Prostate Cancer: Current Clinical Evidence and Key Ongoing Trials
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2021

Expires: June 13, 2022

PARPi monotherapy
Single-Agent PARP Inhibitors in Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2021

Expires: June 14, 2022

Rationale for PARPi Combos
Understanding the Interdependencies of Targeted Pathways: Rationale for PARP Inhibitor Combinations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2021

Expires: June 14, 2022

<i>EP</i>: Prostate Ca PARPi Combos
ExpressPoints
PARP Inhibitor Combinations in Prostate Cancer: Expanding Treatment Options to Broader Patient Populations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

Activities

PARP Combos in Prostate Cancer
PARP Inhibitor Combinations in Prostate Cancer: Expanding Treatment Options to Broader Patient Populations
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2021

Expires: July 06, 2022

Activities

PARPi Combo Evidence in PCa
Expanding the Role of PARP Inhibitors in Prostate Cancer—Innovative Combination Strategies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 02, 2021

Expires: July 01, 2022

Activities

Q&A: PARPi Combos in PCa
Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2021

Expires: June 29, 2022

Podcast Pearls: PARPi Combos in PCa
Podcast Pearls: Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
Multimedia
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2021

Expires: June 29, 2022

Faculty

cover img faculity

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Wassim Abida, MD, PhD

Director of Translational Research, Prostate Cancer
Associate Member
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.